107 related articles for article (PubMed ID: 26632469)
1. [The expression and role of the transcription factor C/EBPα in chronic myeloid leukemia].
Zhang G; Dong F; Luan C; Zhang X; Shao H; Liu J; Sun C
Zhonghua Xue Ye Xue Za Zhi; 2015 Nov; 36(11):947-50. PubMed ID: 26632469
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of CCAAT Enhancer-Binding Protein α Inhibits the Growth of K562 Cells via the Foxo3a-Bim Pathway.
Zhang G; Dong F; Luan C; Zhang X; Shao H; Liu J; Sun C
Acta Haematol; 2016; 136(2):65-70. PubMed ID: 27161125
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional repression of c-Myb and GATA-2 is involved in the biologic effects of C/EBPalpha in p210BCR/ABL-expressing cells.
Soliera AR; Lidonnici MR; Ferrari-Amorotti G; Prisco M; Zhang Y; Martinez RV; Donato NJ; Calabretta B
Blood; 2008 Sep; 112(5):1942-50. PubMed ID: 18550858
[TBL] [Abstract][Full Text] [Related]
4. Aberrantly expressed transcription factors C/EBP and SOX4 have positive effects in the development of chronic myeloid leukemia.
Dong F; Zhang G; Zhang X; Liu X; Wang N; Sun C
Mol Med Rep; 2017 Nov; 16(5):7131-7137. PubMed ID: 28901467
[TBL] [Abstract][Full Text] [Related]
5. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.
Perrotti D; Cesi V; Trotta R; Guerzoni C; Santilli G; Campbell K; Iervolino A; Condorelli F; Gambacorti-Passerini C; Caligiuri MA; Calabretta B
Nat Genet; 2002 Jan; 30(1):48-58. PubMed ID: 11753385
[TBL] [Abstract][Full Text] [Related]
6. [miR-328 Inhibits K562 Cell Proliferation by Up-regulation of C/EBPα Expression].
Cao JX; Wen F; Wang H; Liao P; Li JJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):350-5. PubMed ID: 25948184
[TBL] [Abstract][Full Text] [Related]
7. Correlation of C/EBPα expression with response and resistance to imatinib in chronic myeloid leukaemia.
Kagita S; Uppalapati S; Gundeti S; Digumarti R
Jpn J Clin Oncol; 2015 Aug; 45(8):749-54. PubMed ID: 25920395
[TBL] [Abstract][Full Text] [Related]
8. Restoration of C/EBPalpha expression in a BCR-ABL+ cell line induces terminal granulocytic differentiation.
Tavor S; Park DJ; Gery S; Vuong PT; Gombart AF; Koeffler HP
J Biol Chem; 2003 Dec; 278(52):52651-9. PubMed ID: 14517214
[TBL] [Abstract][Full Text] [Related]
9. [Effect and possible mechanism of HnRNP E2 decoy RNA on proliferation of K562 leukemia cells].
Chen XM; Feng WL; Zhao SQ; Zeng JM; Bai WJ; Wang XZ; Huang ZG
Ai Zheng; 2006 Jul; 25(7):793-7. PubMed ID: 16831266
[TBL] [Abstract][Full Text] [Related]
10. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
[TBL] [Abstract][Full Text] [Related]
11. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
12. [Effect of Stably Down-regulating FMI Expression of K562 Cells on Sensitivity of K562 cells to Imatinib Mesylate].
Han YH; Zhang HX; Hong F; Yu D; Hu CY; Sun Q; Zeng LY; Li ZY; Yan ZL; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):708-716. PubMed ID: 31204920
[TBL] [Abstract][Full Text] [Related]
13. [Gene of DNA-dependent protein kinase catalylic subunit in chronic myeloid leukemia].
Luo J; Peng ZG; Chen Y; Lai YR; Lu YY; Song SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):248-52. PubMed ID: 17493325
[TBL] [Abstract][Full Text] [Related]
14. Silencing of suppressor of cytokine signaling-3 due to methylation results in phosphorylation of STAT3 in imatinib resistant BCR-ABL positive chronic myeloid leukemia cells.
Al-Jamal HA; Jusoh SA; Yong AC; Asan JM; Hassan R; Johan MF
Asian Pac J Cancer Prev; 2014; 15(11):4555-61. PubMed ID: 24969884
[TBL] [Abstract][Full Text] [Related]
15. [Growth inhibition and differentiation of imatinib-resistant chronic myeloid leukemia cell induced by cell differentiation agent in vitro].
Wang XD; Qiu L; Lu RZ; Chen LJ; Zhan ZM; Han BH; Zhang BL; Ma J
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3399-405. PubMed ID: 18476538
[TBL] [Abstract][Full Text] [Related]
16. [SHP-1 gene in the disease progression of chronic myeloid leukemia].
Li Y; Wang X; Yang L; Pan Y; Shang Y; Luo J
Zhonghua Xue Ye Xue Za Zhi; 2014 Dec; 35(12):1074-8. PubMed ID: 25543700
[TBL] [Abstract][Full Text] [Related]
17. The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway.
Wei YL; Liang Y; Xu L; Zhao XY
Anat Rec (Hoboken); 2009 Jul; 292(7):945-50. PubMed ID: 19548306
[TBL] [Abstract][Full Text] [Related]
18. TOPK is regulated by PP2A and BCR/ABL in leukemia and enhances cell proliferation.
Uchida E; Suwa S; Yoshimoto R; Watanabe K; Kasama T; Miura O; Fukuda T
Int J Oncol; 2019 May; 54(5):1785-1796. PubMed ID: 30864683
[TBL] [Abstract][Full Text] [Related]
19. MiR-152-3p promotes the development of chronic myeloid leukemia by inhibiting p27.
Wang L; Wang Y; Lin J
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8789-8796. PubMed ID: 30575920
[TBL] [Abstract][Full Text] [Related]
20. Vitamin Е activates expression of С/EBP alpha transcription factor and G-CSF receptor in leukemic K562 cells.
Shvachko LP; Zavelevich MP; Gluzman DF; Kravchuk IV; Telegeev GD
Exp Oncol; 2018 Dec; 40(4):328-331. PubMed ID: 30593760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]